Clinical pregnancy rate · women trying to conceive by intrauterine insemination
It is very uncertain whether human chorionic gonadotropin (hCG) injection changes clinical pregnancy rate compared with no treatment (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · women trying to conceive by intrauterine insemination
It is very uncertain whether human chorionic gonadotropin (hCG) injection changes multiple pregnancy rate compared with no treatment (very low certainty).
1 finding from 1 review
Clinical pregnancy per woman ‐ oral route · women trying to conceive by intrauterine insemination
It is very uncertain whether progesterone changes clinical pregnancy per woman ‐ oral route compared with no treatment or placebo (route of progesterone administration) (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · women trying to conceive by intrauterine insemination
Progesterone showed no clear difference in multiple pregnancy per woman compared with no treatment or placebo (route of progesterone administration) (low certainty).
1 finding from 1 review
Adverse events, OHSS, preterm delivery, congenital anomaly · women trying to conceive by intrauterine insemination
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth or ongoing pregnancy · women with gonadotropin stimulation
Progesterone showed no clear difference in live birth rate/ongoing pregnancy rate compared with placebo/no treatment (low certainty).
1 finding from 1 review
Miscarriage per clinical pregnancy · women with gonadotropin stimulation
Progesterone showed no clear difference in miscarriage rate per clinical pregnancy compared with placebo/no treatment (low certainty).
1 finding from 1 review
Live birth · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes live birth compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Miscarriage · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes miscarriage compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Viable intrauterine Pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes viable intrauterine pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Ectopic pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes ectopic pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Stillbirth · people having preimplantation genetic testing for monogenic/single gene defects
1 finding from 1 review
Termination of pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes termination of pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Live birth rate per woman · women with infertility
It is very uncertain whether adjuvant growth hormone changes live birth rate per woman randomised compared with no adjuvant: routine use (very low certainty).
1 finding from 1 review
Number of women with at least one oocyte retrieved per woman randomised · women with infertility subclassified as poor responders
Adjuvant growth hormone may leads to higher number of women with at least one oocyte retrieved per woman… compared with no adjuvant: poor responders (low certainty).
1 finding from 1 review
Mean number of oocytes retrieved per woman · women with infertility subclassified as poor responders
1 finding from 1 review
Embryo transfer achieved per woman randomised · women with infertility subclassified as poor responders
It is very uncertain whether adjuvant growth hormone changes embryo transfer achieved per woman randomised compared with no adjuvant: poor responders (very low certainty).
1 finding from 1 review
Mean units gonadotropin used · women with infertility subclassified as poor responders
1 finding from 1 review
Adverse events · women with infertility subclassified as poor responders
1 finding from 1 review
Clinical pregnancy rate · women with infertility
It is very uncertain whether adjuvant growth hormone changes clinical pregnancy rate per woman randomised compared with no adjuvant: routine use (very low certainty).
1 finding from 1 review